Strategic Acquisition Quanta BioDesign has become part of Vector Laboratories, presenting an opportunity to sell into Vector’s established distribution network, broader customer base, and expanded geographic footprint from multiple manufacturing sites in the US to the UK and Europe.

dPEG Expertise The company specializes in proprietary dPEG chemistry for diagnostics and therapeutics, offering tailored cross-linking and labeling solutions that address common development challenges such as poor solubility, short serum half-life, and non-specific interactions—a strong value proposition for partners in drug discovery and diagnostic development.

Expansion Synergy With Vector Laboratories’ recent merges and partnerships, there is potential to cross-sell dPEG-based products alongside an expanded product portfolio and collaborative opportunities highlighted by recent industry awards and strategic alliances.

Executive Exposure New leadership hires and marketing leadership appointments at Vector Labs, plus executive interviews and recognition at industry events, create openings for targeted outreach to decision-makers responsible for reagent sourcing, R&D collaborations, and strategic partnerships.

Digital and Events Active engagement through Vector’s tech stack and participation in high-profile events (AACR, CiteAb) signals channels for prospecting via digital advertising, demand generation, and co-branded seminars or booth appearances that can drive demand for dPEG-enabled solutions.